BUDESONIDE ALDO-UNION 100 micrograms/actuation Suspension for Inhalation in a pressurized container

Introduction

Leaflet: Information for the user

Budesonide Aldo-Union 100 micrograms/puff

inhalation suspension in pressurized container

Read this leaflet carefully before starting to use this medicine, as it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any doubts, consult your doctor, pharmacist, or nurse.
• This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

1. What is Budesonide Aldo-Union 100 micrograms and what is it used for
2. What you need to know before starting to use Budesonide Aldo-Union 100 micrograms
3. How to use Budesonide Aldo-Union 100 micrograms
4. Possible side effects
5. Storage of Budesonide Aldo-Union 100 micrograms
6. Contents of the pack and further information

1. What is Budesonide Aldo-Union 100 micrograms and what is it used for

Budesonide is a non-halogenated corticosteroid effective in the treatment of asthma due to its anti-inflammatory capacity.

It is indicated in:

• Treatment of bronchial asthma, in patients who have not previously responded to therapy with bronchodilators and/or antiallergics.

2. What you need to know before starting to use Budesonide Aldo-Union 100 micrograms

Do not useBudesonide Aldo-Union 100 micrograms:

• If you are allergic to the active substance or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Budesonide Aldo-Union 100 micrograms.

Be particularly careful with this medicine:

This medicine is used as maintenance treatment and should not be used to treat acute asthma attacks (sudden shortness of breath and wheezing). Do not stop treatment with this medicine suddenly.

You should be aware of the possibility of paradoxical bronchospasm with an increase in wheezing after administration. If wheezing appears suddenly after using this medicine, stop using it and consult your doctor immediately, as you may need to change treatment.

Contact your doctor if you experience blurred vision or other visual disturbances.

Important information about some of the components ofBudesonide Aldo-Union 100 micrograms:

Athletes are informed that this medicine contains a component that may result in a positive doping test.

Children and adolescents

There is another presentation, Budesonide Aldo-Union 50 micrograms, specifically indicated for children.

Other medicines andBudesonide Aldo-Union 100 micrograms

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take another medicine.

Some medicines may increase the effects of budesonide, so your doctor will monitor you closely if you are taking these medicines (including some for HIV: ritonavir, cobicistat).

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

This medicine will only be administered during pregnancy or breastfeeding when, in the doctor's opinion, the expected benefit to the mother is greater than any possible risk to the fetus.

Driving and using machines

No effects on the ability to drive or use machines have been described.

Budesonide Aldo-Union 100 micrograms contains ethanol

This medicine contains 0.5 mg of alcohol (ethanol) per inhalation. The amount per inhalation of this medicine is equivalent to less than 1 ml of beer or 1 ml of wine. The small amount of alcohol in this medicine does not produce any noticeable effect.

3. How to use Budesonide Aldo-Union 100 micrograms

Remember to use your medicine.

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

This medicine is administered by inhalation.

The dosage should be individualized.

Unless your doctor has given you different instructions, follow the following posology:

Use in adults

Adults:200-1600 micrograms daily, divided into 2-4 administrations

Use in children and adolescents

Children from 2-7 years:200-400 micrograms daily, divided into 2-4 administrations.

Children from 7 years:200-800 micrograms daily, divided into 2-4 administrations.

Once the desired clinical effects are achieved, your doctor may gradually reduce the dose to the minimum amount necessary to control the symptoms.

If you think the effect of this medicine is too strong or too weak, let your doctor know. Do not change your dose without talking to your doctor first.

Rinse your mouth with water after using the inhaler, do not swallow. This will make it less likely to produce side effects in the mouth or throat.

Instructions for correct administration of the preparation:

Before using the medicine, check the expiration date.

1. Remove the cap (fig.1). If it is a new inhaler or has not been used for several days, shake the aerosol (fig. 2) and perform a puff to ensure the proper functioning of the inhaler. If the inhaler is used regularly, proceed to the next instructions:
2. Shake the inhaler (fig. 2).
3. Eliminate as much air as possible from your lungs.
4. Attach the aerosol to your mouth according to the position indicated in the drawing (fig. 3).
5. Make a deep inhalation.

You should press, according to the arrows in the drawing (fig. 4), the device while making this inhalation.

1. Remove the aerosol from your mouth and try to hold the air in your lungs for a few seconds.
2. You should periodically wash the oral adapter of the aerosol. To do this, remove the adapter from the aerosol and clean it with a cloth or paper towel.
3. Store with the cap on and protect it from dust and dirt.

Your doctor should check that the patient knows how to use the inhaler and synchronizes inhalation with the puff. Optionally, inhalation chambers can be used to achieve better use of the dose and facilitate the arrival of the medicine to the lungs.

The inhaler has a dose indicator that can be seen through a small hole or window of the actuator and indicates how many applications are left. In this indicator of a new inhaler, you can read "200" through the window of the actuator. These numbers correspond to the doses left in the inhaler. As the inhaler is used, the dose indicator rotates in a decreasing manner every 5-7 puffs until it reaches 0.

When there are approximately 40 doses left, the indicator changes from green to red (see figure 5) to remind the patient to consult their doctor if they need to continue treatment or need a new prescription. Discard the inhaler once the indicator reaches "0".

(figure 5)

If you use moreBudesonide Aldo-Union 100 microgramsthan you should

It is important that you take your dose as indicated by your doctor. Do not increase or decrease your dose without medical supervision.

Although no toxic symptoms are expected in case of overdose or accidental ingestion, if you have inhaled more budesonide than you should, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone 91 562 04 20.

If you observe symptoms such as edema, swelling of the face or moon face, etc., you should inform your doctor so that the appropriate measures can be taken.

If you forget to use Budesonide Aldo-Union 100 micrograms

Do not use a double dose to make up for forgotten doses.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Ocasional cases of mild throat irritation, cough, and hoarseness have been described. Similarly, cases of overinfection by Candida in the oral, pharyngeal, and laryngeal cavities have been reported. In most cases, they respond to topical antifungal therapy without the need to interrupt treatment with budesonide. In exceptional cases, cutaneous allergic reactions (urticaria, dermatitis) associated with the use of topical corticosteroids have been described.

You should be aware of the possibility of paradoxical bronchospasm with an increase in wheezing after administration. If wheezing appears suddenly after using this medicine, stop using it and consult your doctor immediately, as you may need to change treatment.

Frequency not known (cannot be estimated from available data):

Sleep disturbances, depression or feeling of concern, restlessness, nervousness, excitability or irritability (these effects are more likely to occur in children), and blurred vision (see also section 2: Warnings and Precautions).

If you experience side effects, consult your doctor or pharmacist or nurse, even if they are not listed in this leaflet.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that is not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Budesonide Aldo-Union 100 micrograms

Keep this medicine out of the sight and reach of children.

Store below 30°C. Protect from direct sunlight and do not freeze or chill.

The container contains a pressurized liquid. Do not expose to temperatures above 50°C. Do not puncture the container even when empty.

Do not use this medicine after the expiration date stated on the carton after CAD:. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the container and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the container and any unused medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition ofBudesonide Aldo-Union 100 micrograms

The active substance is budesonide.

Each inhalation contains 100 micrograms of budesonide.

The other components are oleic acid, ethanol, and norflurane.

Appearance of the product and contents of the pack

Budesonide Aldo-Union 100 micrograms is presented as an inhalation suspension in a pressurized container with a dose indicator in a 10 ml container that allows for 200 applications.

Marketing authorization holder and manufacturer

Laboratorio Aldo-Unión, S.L.

Baronesa de Maldá, 73

08950 Esplugues de Llobregat (Barcelona)

Spain

Date of last revision of this leaflet:March 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es